Furthermore, Chen et al. demonstrated that TRAF3 brought about significant elevations in metabolic inflammation and metabolic disease progression in hepatic steatosis, while TRAF3 inhibition was associated with reduced levels of inflammation [32]. This evidence concerns the gene TRAF3 and metabolic disease.